Mahmud Kamani, boohoo co-founder Mahmud Kamani has joined forces with Richard Hughes, founder of investment bank Zeus Capital, to launch direct-to-consumer sales of a saliva-based rapid test for the Covid-19 antigen.

“We immediately recognised the global opportunity to distribute the simple and unique saliva-based COVID-19 rapid test being developed by Avacta based on their unique and powerful Affimer platform. Medusa19 will enable end-to-end supply of these tests on a global basis subject to regulatory approval – and manufacturing capacity which will be key.”

“The enormous, worldwide demand for these tests requires a robust and scalable platform which we are in the process of creating. Hundreds of millions of tests are required and this demand will continue. Given this test will be saliva based, it could be used in airports, offices, factories and in the home environment, providing a result within minutes and with no requirement for medical supervision. It is potentially ground-breaking and a major step forward in the fight against COVID-19.” – said Hughes and Kamani.